8
Jun 2026
Living in a rural area may worsen epilepsy outcomes
A study reveals rural Americans with epilepsy face higher mortality and diagnostic gaps, emphasizing the need for improved healthcare access and resources.
8
Jun 2026
A study reveals rural Americans with epilepsy face higher mortality and diagnostic gaps, emphasizing the need for improved healthcare access and resources.
8
Jun 2026
Black women experience disproportionately elevated risks of developing and dying from early-onset breast cancer. New research published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, reveals the genes that are most likely to be mutated to contribute to these increased risks.
8
Jun 2026
Brain stimulation techniques can correct abnormal activity in the neural circuits involved in conditions such as Parkinson's disease and depression. However, current transcranial stimulation methods delivered through the scalp reach only the brain's surface, limiting their effectiveness.
8
Jun 2026
Researchers from ETH Zurich have developed an active ingredient that slows down the progression of typical Alzheimer’s symptoms in mice. This new substance protects nerve cells and could in future alleviate the suffering of Alzheimer’s patients. The active ingredient also shows anti-aging effects.
8
Jun 2026
A light, flexible polymer material developed at the University of Waterloo could replace the lead in heavy X-ray aprons, providing the same protection from harmful radiation while reducing their weight by almost 90 per cent.
8
Jun 2026
The TORCH complex is a group of pathogens that can cause infections with mild or silent symptoms in an expecting mother, but in a developing fetus can lead to serious complications that include stillbirth, lifelong disability, or birth defects.
7
Jun 2026
A study of more than 229,000 obese adults without diabetes in the United States has shown that weight loss drugs are associated with a decreased risk of obesity-related cancers.
7
Jun 2026
Plenty of studies have linked exposure to nature to a wide variety of health benefits, from improved cognitive function to lower blood pressure to better mental health.
7
Jun 2026
Among adults with both obesity and an autoimmune disease, those taking a glucagon-like peptide-receptor 1 agonist (GLP-1RA) medication had lower rates of emergency department visits and were less likely to experience serious cardiac events, such as stroke, pulmonary embolism or death when compared to similar adults who were not taking these medications, according to new research published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.
7
Jun 2026
Infections should be considered a "health hazard" in people living with diabetes, with experts warning that current clinical guidelines fail to reflect a substantial but under-recognized burden of illness, hospitalization and death.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more